UpToDate competitors
UpToDate Competitors include Hanger, Advanced Oncotherapy, Affymetrix and Fusion Antibodies.
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  Hanger Empowering human potential with innovative technologies, efficient and effective clinical solutions, and outstanding customer service. |  Advanced Oncotherapy Advanced Oncotherapy is a medical technology company providing advanced radiotherapy systems for the treatment of common and rare cancers. |  Affymetrix Affymetrix now develops and provides innovative technologies that enable multiplex and parallel analysis of biological systems at the cell, |  Fusion Antibodies Fusion Antibodies is a CRO that offers a range of world class services in antibody production, development, characterization and optimization. | |
Founding Date | Founding Date 1992 | Founding Date 1861 | Founding Date 1994 | Founding Date 1994 | Founding Date 2001 |
Type | Type Subsidiary | Type Public | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Waltham, US HQ Zoetermeer, NL | Locations Austin, US HQ | Locations London, GB HQ Rolle, CH Syracuse, US | Locations Santa Clara, US HQ Vienna, AT Shanghai, CN Singapore, SG High Wycombe, GB Southfield, US see more | Locations Dunmurry, GB HQ |
Employees | Employees N/A | Employees 4,600 | Employees 51 | Employees N/A | Employees 30 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 757.6 m | Valuation ($) 28.9 m | Valuation ($) N/A | Valuation ($) N/A |
Twitter followers | Twitter followers N/A | Twitter followers 2.4 k | Twitter followers 804 | Twitter followers 9.8 k | Twitter followers 780 |
Financial ⚠ | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1b (FY, 2017) | Revenue (est.) N/A | Revenue (est.) $359.8m (FY, 2015) | Revenue (est.) £2.7m (FY, 2018) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $110.8m (FY, 2015) | Cost of goods £1.2m (FY, 2018) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $249m (FY, 2015) | Gross profit £1.5m (FY, 2018) |
Net income | Net income N/A | Net income ($104.7m) (FY, 2017) | Net income (£13.7m) (FY, 2017) | Net income $10.1m (FY, 2015) | Net income (£699.9k) (FY, 2018) |
For sources of this data, please see the company profileDownload Excel
View company profiles
Hanger
HQ
Austin, US
Employees
4,600
Empowering human potential with innovative technologies, efficient and effective clinical solutions, and outstanding customer service.
View companyAdvanced Oncotherapy
HQ
London, GB
Employees
51
Advanced Oncotherapy is a medical technology company providing advanced radiotherapy systems for the treatment of common and rare cancers.
View companyAffymetrix
HQ
Santa Clara, US
Affymetrix now develops and provides innovative technologies that enable multiplex and parallel analysis of biological systems at the cell,
View companyFusion Antibodies
HQ
Dunmurry, GB
Employees
30
Fusion Antibodies is a CRO that offers a range of world class services in antibody production, development, characterization and optimization.
View company